TITLE

Novel Treponema pallidum Serologic Tests: A Paradigm Shift in Syphilis Screening for the 21st Century

AUTHOR(S)
Seña, Arlene C.; White, Becky L.; Sparling, P. Frederick
PUB. DATE
September 2010
SOURCE
Clinical Infectious Diseases;9/15/2010, Vol. 51 Issue 6, p700
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The mainstay of diagnosis for Treponema pallidum infections is based on nontreponemal and treponemal serologic tests. Many new diagnostic methods for syphilis have been developed, using specific treponemal antigens and novel formats, including rapid point-of-care tests, enzyme immunoassays, and chemiluminescence assays. Although most of these newer tests are not yet cleared for use in the United States by the Food and Drug Administration, their performance and ease of automation have promoted their application for syphilis screening. Both sensitive and specific, new screening tests detect antitreponemal IgM and IgG antibodies by use of wild-type or recombinant T. pallidum antigens. However, these tests cannot distinguish between recent and remote or treated versus untreated infections. In addition, the screening tests require confirmation with nontreponemal tests. This use of treponemal tests for screening and nontreponemal serologic tests as confirmatory tests is a reversal of long-held practice. Clinicians need to understand the science behind these tests to use them properly in syphilis management.
ACCESSION #
53390797

 

Related Articles

  • Qualitative and quantitative aspects of the serological diagnosis of early syphilis. McMillan, A.; Young, H. // International Journal of STD & AIDS;Sep2008, Vol. 19 Issue 9, p620 

    The aim of the present study was to evaluate the use of various serological tests in the diagnosis of early syphilis. The Murex enzyme immunoassay (EIA) test was used for screening; the Venereal Diseases Research Laboratory (VDRL) test, the Treponema pallidum particle agglutination assay (TPPA)...

  • Enzywell recombinant enzyme immunoassay for the serological diagnosis of syphilis. Young, H.; Aktas, G.; Moyes, A. // International Journal of STD & AIDS;May2000, Vol. 11 Issue 5, p255 

    The aim of this study was to evaluate Enzywell TP, a new rapid enzyme immunoassay (EIA) that uses 2 recombinant Treponema pallidum antigens for the serological diagnosis of syphilis. Specificity was evaluated by screening 1055 unselected bloods requesting serological tests for syphilis in...

  • Discordant Results from Reverse Sequence Syphilis Screening -- Five Laboratories, United States, 2006-2010. Radolf, J. D.; Bolan, G; Park, IU; Chow, JM; Schillinger, JA; Pathela, P; Blank, S; Zantao, SN; Hoover, KA; Ballard, RC // MMWR: Morbidity & Mortality Weekly Report;2/11/2011, Vol. 60 Issue 5, p133 

    The article discusses the results of an analysis conducted by the U.S. Centers for Disease Control and Prevention (CDC) on reverse sequence screening for syphilis from 2006 to 2010. The analysis found that enzyme and chemiluminescence immunoassays (EIA/CIA) had a nonreactive rapid plasma reagin...

  • The Trade-Off between Accuracy and Accessibility of Syphilis Screening Assays. Smit, Pieter W.; Mabey, David; Changalucha, John; Mngara, Julius; Clark, Benjamin; Andreasen, Aura; Todd, Jim; Urassa, Mark; Zaba, Basia; Peeling, Rosanna W. // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    The availability of rapid and sensitive methods to diagnose syphilis facilitates screening of pregnant women, which is one of the most cost-effective health interventions available. We have evaluated two screening methods in Tanzania: an enzyme immunoassay (EIA), and a point-of-care test (POCT)....

  • THE SCHISTOSOMULA TEGUMENT ANTIGEN AS A POTENTIAL CANDIDATE FOR THE EARLY SEROLOGICAL DIAGNOSIS OF SCHISTOSOMIASIS MANSONI. GRENFELL, Rafaella; MARTINS, Watson; SILVA-MORAES, Vanessa; ARAUJO, Neusa; OLIVEIRA, Edward; FONSECA, Cristina; Zech COELHO, Paulo Marcos // Revista do Instituto de Medicina Tropical de Sao Paulo;Mar/Apr2013, Vol. 55 Issue 2, p75 

    If Schistosoma mansoni infection could be detected in its early stages, especially before the egg deposition in the host tissues, the development of severe pathologic lesions could be efficiently prevented. We therefore developed an indirect enzyme-linked immunosorbent assay based on the...

  • Comparing the performance of traditional non-treponemal tests on syphilis and non-syphilis serum samples. Gu, Wei-Ming; Yang, Yang; Wang, Qing-zhong; Pan, Bai-shen; Guo, Wei; Wu, Lei; Hu, Wei-zhong; Yang, Sheng; Song, Bin-bin; Zhang, Chun-yan // International Journal of STD & AIDS;Dec2013, Vol. 24 Issue 12, p919 

    The goal of the present study was to determine the performance of two traditional non-treponemal tests for syphilis. Syphilis sera (n = 209) included different stages of disease, and control sera (n = 247) were from patients with tumours, leprosy, systemic lupus...

  • Sensitivity and Specificity of Point-of-Care Rapid Combination Syphilis-HIV-HCV Tests. Hess, Kristen L.; Fisher, Dennis G.; Reynolds, Grace L. // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Background: New rapid point-of-care (POC) tests are being developed that would offer the opportunity to increase screening and treatment of several infections, including syphilis. This study evaluated three of these new rapid POC tests at a site in Southern California. Methods: Participants...

  • Use of cerebrospinal fluid enzyme immunoassay for diagnosis of neurosyphilis. Chan, Yung; Yeung, Kwok-Hung; Ho, Hing-Fung; Ho, King-Man; Tin-Keung Lam, Edman; Leung, Wai-Lin; Kam, Kai-Man // International Journal of STD & AIDS;Jul2014, Vol. 25 Issue 8, p571 

    Neurosyphilis is a difficult clinical stage of syphilis as there is no ideal method for diagnosis and workup requires lumbar puncture which may sometimes provide ambiguous results especially in HIV co-infected patients. Enzyme immunoassay is a widely used screening test for syphilis in serum,...

  • Use of recombinant chimeric antigens for the serodiagnosis of Mycoplasma pneumoniae infection. Montagnani, F.; Paolis, F.; Beghetto, E.; Gargano, N. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2010, Vol. 29 Issue 11, p1377 

    In this paper, we have evaluated the diagnostic utility of three antigenic regions of the Mycoplasma pneumoniae P1, P30, and MPN456 gene products in order to replace the soluble, whole-cell bacterial extract in serological assays. Antigenic regions, being previously identified as B-cell...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics